Zealand Pharma A/S is a biotechnology company that develops peptide-based medicines. The company's focus is on the discovery, design, and development of innovative peptide-based medicines that can help improve the lives of patients suffering from metabolic and gastrointestinal diseases. Zealand Pharma A/S has a pipeline of product candidates in various stages of development, including both clinical and preclinical programs. The company was founded in 1998 and is headquartered in Copenhagen, Denmark.